
HZNP
Healthcare · Drug Manufacturers - General · $26.63B market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2023
EPS trend, 90 days to now · -10.9% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 28, 2024 | Time not confirmed | 1.36 | 0.00 | -100.0% |
| Nov 8, 2023 | Time not confirmed | 1.19 | 0.00 | -100.0% |
| Aug 8, 2023 | Before the open | 1.03 | 1.20 | +16.5% |
| May 3, 2023 | Before the open | 1.12 | 0.83 | -25.9% |
| Mar 1, 2023 | Before the open | 1.09 | 1.21 | +11.0% |
| Nov 2, 2022 | Before the open | 1.01 | 1.25 | +23.8% |
| Aug 3, 2022 | Before the open | 1.34 | 1.07 | -20.1% |
| May 4, 2022 | Before the open | 1.14 | 1.34 | +17.5% |
| Mar 1, 2022 | Before the open | 1.35 | 1.41 | +4.4% |
| Nov 3, 2021 | Before the open | 1.54 | 1.75 | +13.6% |
| Aug 4, 2021 | Before the open | 0.88 | 1.62 | +84.1% |
| May 5, 2021 | Before the open | 0.05 | 0.03 | -40.0% |
| Feb 24, 2021 | Before the open | 1.06 | 1.28 |
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion;…
| +20.8% |
| Nov 2, 2020 | Before the open | 0.97 | 1.74 | +79.4% |
| Aug 5, 2020 | Before the open | 0.36 | 0.40 | +11.1% |
| May 6, 2020 | Before the open | 0.21 | 0.40 | +90.5% |
| Feb 26, 2020 | Before the open | 0.42 | 0.56 | +33.3% |
| Nov 6, 2019 | Before the open | 0.49 | 0.64 | +30.6% |
| Aug 7, 2019 | Before the open | 0.38 | 0.49 | +28.9% |
| May 8, 2019 | Before the open | 0.12 | 0.30 | +150.0% |
| Feb 27, 2019 | Before the open | 0.54 | 0.67 | +24.1% |
| Nov 7, 2018 | Before the open | 0.49 | 0.65 | +32.7% |
| Aug 8, 2018 | Before the open | 0.31 | 0.48 | +54.8% |
| May 9, 2018 | Before the open | 0.06 | 0.03 | -50.0% |
| Feb 28, 2018 | Before the open | 0.22 | 0.29 | +31.8% |